Abstract:Metabolic byproducts of the intestinal microbiota are crucial in maintaining host immune tone and shaping inter-species ecological dynamics. Among these metabolites, succinate is a driver of tuft cell (TC) differentiation and consequent type 2 immunity-dependent protection against invading parasites in the small intestine. Succinate is also a growth enhancer of the nosocomial pathogen in the large intestine. To date, no research has shown the role of succinate in modulating TC dynamics in the large intestine, or the relevance of this immune pathway to pathophysiology. Here we reveal the existence of a three-way circuit between commensal microbes, and host epithelial cells which centers around succinate. Through selective microbiota depletion experiments we demonstrate higher levels of type 2 cytokines leading to expansion of TCs in the colon. We then demonstrate the causal role of the microbiome in modulating colonic TC abundance and subsequent type 2 cytokine induction using rational supplementation experiments with fecal transplants and microbial consortia of succinate-producing bacteria. We show that administration of a succinate-deficient knockout (Δfrd) significantly reduces the enhanced type 2 immunity in mono-colonized mice. Finally, we demonstrate that mice prophylactically administered with the consortium of succinate-producing bacteria show reduced -induced morbidity and mortality compared to mice administered with heat-killed bacteria or the vehicle. This effect is reduced in a partial tuft cell knockout mouse, , and nullified in the tuft cell knockout mouse, , confirming that the observed protection occurs the TC pathway. Succinate is an intermediary metabolite of the production of short-chain fatty acids, and its concentration often increases during dysbiosis. The first barrier to enteric pathogens alike is the intestinal epithelial barrier, and host maintenance and strengthening of barrier integrity is vital to homeostasis. Considering our data, we propose that activation of TC by the microbiota-produced succinate in the colon is a mechanism evolved by the host to counterbalance microbiome-derived cues that facilitate invasion by intestinal pathogens.

Sequestration of gut pathobionts in intraluminal casts, a mechanism to avoid dysregulated T cell activation by pathobionts

The absence of interleukin 10 affects the morphology, differentiation, granule content and the production of cryptidin-4 in Paneth cells in mice

A conserved Bacteroidetes antigen induces anti-inflammatory intestinal T lymphocytes

Endocytosis of commensal antigens by intestinal epithelial cells regulates mucosal T cell homeostasis

A host-adapted auxotrophic gut symbiont induces mucosal immunodeficiency

[Commensal bacteria prevent pathogenic bacterial infection by inducing of activation of host immune system]

Intestinal Microbiota as a Host Defense Mechanism to Infectious Threats

Dysfunction of Foxp3+ Regulatory T Cells Induces Dysbiosis of Gut Microbiota via Aberrant Binding of Immunoglobulins to Microbes in the Intestinal Lumen

Class Ib MHC-Mediated Immune Interactions Play a Critical Role in Maintaining Mucosal Homeostasis in the Mammalian Large Intestine

Selected commensals educate the intestinal vascular and immune system for immunocompetence

Host innate and adaptive immunity shapes the gut microbiota biogeography

Symbiotic Firmicutes establish mutualism with the host via innate tolerance and resistance to control systemic immunity

Induction of intercrypt goblet cells upon bacterial infection: a promising therapeutic target to restore the mucosal barrier

Microbiota encoded fatty-acid metabolism expands tuft cells to protect tissues homeostasis during infection in the large intestine

Giardia Infection of the Small Intestine Induces Chronic Colitis in Genetically Susceptible Hosts

A RORγt+ cell instructs gut microbiota-specific Treg cell differentiation

Epithelial IFNγ signalling and compartmentalized antigen presentation orchestrate gut immunity

Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness

Acquisition of a multifunctional IgA+ plasma cell phenotype in the gut

The gut mucosal immune response to Toxoplasma gondii

A type 1 immune-stromal cell network mediates disease tolerance and barrier protection against intestinal infection